Mercer Global Advisors
LPCN icon

Mercer Global Advisors’s Lipocine LPCN Stock Holding History

Mercer Global Advisors’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,359
Closed -$63K – 2004
2022
Q4 		$63K Hold
9,359
– – ﹤0.01% 1852
2022
Q3 		$72K Sell
9,359
-8,824
-49% -$98.5K ﹤0.01% 1747
2022
Q2 		$248K Hold
18,183
– – ﹤0.01% 1515
2022
Q1 		$423K Sell
18,183
-235
-1% -$4.92K ﹤0.01% 1315
2021
Q4 		$310K Hold
18,418
– – ﹤0.01% 1448
2021
Q3 		$341K Buy
18,418
+1,176
+7% +$25.9K ﹤0.01% 1370
2021
Q2 		$410K Buy
17,242
+4,818
+39% +$113K ﹤0.01% 1236
2021
Q1 		$319K Sell
12,424
-4,706
-27% -$136K ﹤0.01% 1282
2020
Q4 		$396K Buy
17,130
+2,941
+21% +$70.8K ﹤0.01% 960
2020
Q3 		$340K Sell
14,189
-1,812
-11% -$48.1K 0.01% 911
2020
Q2 		$343K Buy
16,001
+8,922
+126% +$116K 0.01% 804
2020
Q1 		$58K Buy
7,079
+2,941
+71% +$23.3K ﹤0.01% 1037
2019
Q4 		$27K Sell
4,138
-3,521
-46% -$90.2K ﹤0.01% 1160
2019
Q3 		$365K Sell
7,659
-2,353
-24% -$94.5K 0.01% 822
2019
Q2 		$332K Sell
10,012
-2,471
-20% -$76.3K 0.01% 836
2019
Q1 		$490K Buy
+12,483
New +$383K 0.02% 639

Other funds holding LPCN

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mercer Global Advisors's LPCN Position: Q1 2023 in Review

Mercer Global Advisors sold out of Lipocine (LPCN) in Q1 2023, closing a stake of 9,359 shares — an estimated $63K sold.

Mercer Global Advisors first reported a position in LPCN in Q1 2019 and held it in 16 quarters. The position peaked at $490K in Q1 2019. 45 funds tracked by Wall St. Rank hold LPCN as of Q1 2023.

  • Mercer Global Advisors reported no remaining Lipocine position as of Q1 2023 after selling out during the quarter.
  • Mercer Global Advisors sold 9,359 Lipocine shares in Q1 2023, an estimated $63K.
  • Mercer Global Advisors first reported a position in Lipocine in Q1 2019 and held it in 16 quarters.
  • Mercer Global Advisors's Lipocine position peaked at $490K in Q1 2019.
  • 45 funds tracked by Wall St. Rank held Lipocine as of Q1 2023.

Based on Mercer Global Advisors's 13F filing for Q1 2023, filed 16 May 2023.